INTRODUCTION {#sec1-1}
============

Eosinophilic granuloma (EG) is a benign lytic lesion of bone characterized by increased histiocytes. It is classified with Hand-Schüller-Christian and Letterer-Siwe diseases as a member of the reticuloendothelial disorder group, Langerhans' Cell Histiocytosis (LCH). In 1953, Lichtenstein grouped this disease under the name histiocytosis X.\[[@ref1]\] The "X" referred to the fact that the etiology was unknown. However, in 1987, the term "Langerhans' Cell Histiocytosis" (LCH) was introduced by the "Writing Group of the Histiocyte Society".\[[@ref2]\] Eosinophilic granuloma is the most common benign lesion and accounts for 50-60% of all cases of this disease.\[[@ref3][@ref4]\] It can affect almost any bone and commonly involves the mandible when the jaws are affected.\[[@ref5]--[@ref7]\]

Eosinophilic granuloma has been treated with surgery, radiotherapy, chemotherapy and intralesional steroid injections.\[[@ref5][@ref8][@ref9]\] Recurrence rate in multifocal eosinophilic granuloma is high. Most of the authors advised mandibular resection for recurrent lesions. In the present case, after the first recurrence, systemic and intralesional corticosteroids with surgical curettage were given to the patient. The clinical and radiographical changes observed during two years of duration are reported in the present paper with special emphasis on intralesional corticosteroids in the management of eosinophilic granuloma.

CASE REPORT {#sec1-2}
===========

A 51-year-old female referred to our department with the complaint of pain and swelling in the left mandibular region since two years. During systemic history, patient revealed low back pain, hypertension and diabetic mellitus Type 2 since 10-11 years. She underwent surgery of the maxillary sinus region which as per her previous records was treated with FESS (functional endoscopic sinus surgery), left conchaplasty with widening of maxillary sinus. The biopsied tissue of the ophthalmic and maxillary region showed inflammatory cells and was not suggestive of any malignancy. During course of time patient underwent root canal treatments of mandibular molars, premolars and incisors for her dental pain. However, the pain did not subside and patient referred to our department. On examination pain was mild, dull, and localized in nature. The family history of the patient was not contributory. Physical examination showed facial asymmetry attributable to diffuse swelling of the left mandibular region. Mouth opening and sensation over the distribution of the left inferior alveolar nerve was normal. Intraorally, the alveolar ridge posterior to the right first molar was covered with intact, normal-appearing mucosa. No teeth showed mobility or pain on percussion. There was no cervical or axillary lymphadenopathy. A two-year-old panoramic radiograph \[[Figure 1](#F1){ref-type="fig"}\] showed an ill-defined osteolytic lesion in the left posterior mandibular body, with involvement of the apices of both the first molar and the second molar and in the anterior part of the mandible involving the incisors and premolars of the left side of the mandible. However, a recent panoramic radiograph showed massive increase of erosion in the posterior and anterior part of the mandible \[[Figure 2](#F2){ref-type="fig"}\].

![Old orthopantomogram depicting osteolytic lesions in the left mandibular posterior and anterior part in the year 2007](DRJ-9-821-g001){#F1}

![Orthopantomogram showing increase in the radiolucency and the size of the lesions after two years (2009)](DRJ-9-821-g002){#F2}

Because the clinical and radiographic findings led to suspicion of a malignancy, surgical intervention with biopsy of the lesion was planned and performed. The specimen, which was friable and resembled granulation tissue, showed a proliferation of histiocytic cells and an infiltration of eosinophils and neutrophils on microscopic examination. Soft-tissue fragments permeated by hematopoietic cells and predominantly mononuclear cells with clefted nuclei and granular cytoplasm were seen admixed with eosinophils, neutrophils and lymphocytes \[[Figure 3](#F3){ref-type="fig"}\]. Immunohistochemical staining showed that the histiocytic cells were positive for the CD 68, CD1a, S-100 protein \[Figures [4](#F4){ref-type="fig"}--[6](#F6){ref-type="fig"}\], and Myeloperoxidaes were positive in the surrounding granulocytes. The CD 45 was also positive in lymphocytes \[[Figure 6](#F6){ref-type="fig"}\].

![Histopathological picture showing predominantly mononuclear cells with clefted nuclei and granular cytoplasm admixed with eosinophils, neutrophils and lymphocytes](DRJ-9-821-g003){#F3}

![Immunohistochemistry showing that histiocytic cells were positive for the CD 68](DRJ-9-821-g004){#F4}

![Immunohistochemistry showing that histiocytic cells were positive for the CD 1A](DRJ-9-821-g005){#F5}

![Immunohistochemistry showing that histiocytic cells were positive for the S-100 protein](DRJ-9-821-g006){#F6}

These features were consistent with a diagnosis of eosinophilic granuloma. To evaluate the possibility of systemic histiocytosis X, a radiographic skeletal survey and a visceral ultrasound was performed. These examinations detected no other lesions except a few changes in sacroiliac joint. The results of laboratory tests, consisting of blood and serum biochemical studies, were within normal ranges except there was a significant increase in ESR observed. A chest radiograph did not show any significant abnormality. Consequently, the mandibular lesion was diagnosed as eosinophilic granuloma. After three weeks of surgery the mandibular swelling decreased rapidly, and there was marked improvement in the facial asymmetry. Patient reported again after one year to us with a pain in the right mandibular posterior region. Computed tomography (CT) scans showed a destructive bony lesion extending from the mesial side of the right first premolar to the distal side of the second premolar \[[Figure 7](#F7){ref-type="fig"}\]. A separate well-defined new radiolucent lesion was observed distal to the left mandibular first molar \[[Figure 8](#F8){ref-type="fig"}\].

![Computed tomography scan](DRJ-9-821-g007){#F7}

![A separate well-defined new radiolucent lesion observed distal to the left mandibular first molar](DRJ-9-821-g008){#F8}

Second surgery with curettage of the lesion was done along with biweekly intralesional 40 mg injections of methylprednisolone in the posterior lesion for the next eight weeks. The patient was also given systemic steroid Defcort 6 mg (Deflazacortil, Mehius India) per day for 30 days in a tapering manner along with surgical curettage. The patient was evaluated after every six months for the next two years. Patient was free of symptoms and signs and her radiographs revealed healed lesions in the anterior and posterior part of the mandible \[[Figure 9](#F9){ref-type="fig"}\].

![Post-treatment orthopantomogram showing complete bone formation distal to the left mandibular first molar](DRJ-9-821-g009){#F9}

DISCUSSION {#sec1-3}
==========

Eosinophilic granuloma, known as benign localized LCH, represents the most common form of this disease and presents single or multiple skeletal lesions. Solitary lesions are more common than multiple lesions. When multiple lesions occur, the new osseous lesions appear within 1-2 years, and the condition is still classified as eosinophilic granuloma. Radiologically this lesion is characterized by destructive lytic bone lesion, edges of which may be bevelled, scalloped or confluent (geographic), or show a "button sequestrum".\[[@ref10][@ref11]\]

Choosing the treatment option for eosinophilic granuloma is highly debatable. Treatment of eosinophilic granuloma is important because local expansion can cause destruction of the bone and sometimes fracture of the jaw.\[[@ref12][@ref13]\] Eosinophilic granuloma has been conventionally treated with surgery, radiotherapy, chemotherapy, and steroid injections, alone or in combination.\[[@ref3][@ref7][@ref8]\] However, a few reports have described spontaneous resolution after biopsy.\[[@ref14]\] The major drug modalities available and which have shown good results include methyl prednisolone, 2-Chlorodeoxyadenosine,\[[@ref15]\] etoposide, 2-deoxycoformin,\[[@ref16]\] vinblastine,\[[@ref17]\] mercaptopurine, methotrexate, interferon and interleukin. Comparing the two different trials conducted by Histiocyte Society and "DAL/HX 83", the later showed a better response rate and mortality in which six weeks' initial treatment with methylprednisone, vinblastin and etoposide was given followed by mercaptopurine, vinblastin and prednisolone for one year.\[[@ref18]\] In addition to many therapeutic combinations including surgery, chemotherapy and radiation, new therapeutic strategies are represented by monoclonal CD-1a-antibody-therapy\[[@ref19]\] and gene transfer into hemopoietic progenitor cells.\[[@ref19][@ref20]\]

Curettage of the lesion has been suggested but complete removal of the lesion is not necessary in most cases. Intralesional corticosteroids were used along with the surgical curettage because of the fact that surgical curettage alone showed recurrence of the lesion as well as appearance of new lesion \[[Figure 8](#F8){ref-type="fig"}\]. The role of corticosteroids in the treatment of eosinophilic granuloma is well documented.\[[@ref4][@ref20][@ref21]\] Methylprednisolone is an effective immunosuppressive and anti-inflammatory agent when administered systemically and is effective in bone cysts as it destroys granulomatous tissue and induces osteogenesis.\[[@ref3]\] Harris and Woo reviewed a series of seven patients with LCH of the orbit. Two patients were treated with biopsy and low-dose radiation and five patients had subtotal curettage at the time of biopsy; four of five received simultaneous intralesional corticosteroid injection, no local recurrence or additional focus was noted in follow-up periods of 1 to 17 years.\[[@ref22]\]

In our case when the patient was evaluated after one year of surgery, a new lesion was seen as on radiograph \[[Figure 8](#F8){ref-type="fig"}\]. After discussion it was decided to give biweekly intralesional injection of methylprednisolone 40 mg and systemic steroid Defcort 6 mg (Deflazacortil, Mehius India) per day for 30 days in a tapering manner along with surgical curettage. Accessible lesions are best managed by curettage\[[@ref11][@ref23]--[@ref26]\] which can be done intraorally. When these lesions are not accessible by curettage or if the operation will result in a gross disfigurement, low-dose radiation of 6-10 Gy or chemotherapy can be used.\[[@ref5][@ref25]\] The recurrence rate of eosinophillic granuloma ranges from 1-25%, depending on the treatment protocol and the location of the lesion.\[[@ref5][@ref7]\] Postovsky\[[@ref27]\] recommends mandibulectomy in case of recurrence.

There are a variety of therapeutic approaches to multifocal eosinophillic granuloma. Taking into account a propensity to spontaneous healing of some of these lesions, it may be prudent to leave them without any therapeutic intervention, if the lesions do not pose a direct danger to the functioning of adjacent structures or cause major cosmetic defects.\[[@ref26][@ref27]\] In the present case, the patient was symptomatic with regard to the multiple, small lesions in her mandible. Therefore a "wait and watch" strategy could not be applied for these lesions. According to the literature, there are only two reports associated with spontaneous remission of Langerhans' cell histiocytosis after biopsy.\[[@ref6][@ref27]\] In the present case, the patient was followed up clinically and radiographically for two years. After three weeks of intralesional methylprednisone injection and systemic corticosteroid with surgical curettage, remissions associated with clinical and radiographic improvement have occurred in the jaws.

CONCLUSION {#sec1-4}
==========

Eosinophilic granuloma often presents with a wide range of clinical symptoms and sometimes with an unpredictable clinical course requiring multiple surgical as well as non-surgical interventions. We provide additional and independent evidence of the efficacy of intralesional and systemic corticosteroids in the management of recurrent polyostotic eosinophilic granuloma of the mandible. This method is also minimally invasive and relatively inexpensive, although some adverse effects are possible. Further studies are required to evaluate the safety and efficacy of this treatment.
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